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B-RaF is a member of the RAF family of serine/threonine
kinases involved in the regulation of cell growth, differen-
tiation, and proliferation. It forms part of a conserved
apoptosis signals through the RAS-RAF-MAPK pathway.
As an important target of the cancer treatment B-Raf has
more potential for researcher. The discovery of the
V600EB-RAF mutation [1] has elevated expectation for tar-
geted therapy against human melanoma. In the current
work the molecular modeling study were carried out very
first time with 3D-QSAR studies [2] by correlating the
docking protocol for three different datasets of B-Raf
inhibitors. Based on the co-crystallized compound (PDB
ID: 1UWJ), several alignment methods were utilized to
derive reliable CoMFA and CoMSIA models. The best
CoMFA model (q
2 =0.753, r
2 =0.807). With the same
alignment protocol, a statistically reliable CoMSIA model
# 14 was also derived (q
2 =0 . 9 6 2 ,r
2 =0 . 9 6 1 ) .T h ea c t u a l
predictive powers of both models were thoroughly vali-
dated with an external test set, which gave satisfactory
predictive r
2 values of 0.89 and 0.90, respectively.
Contour maps from CoMFA and CoMSIA models, sup-
porting the statistical results and revealed important
structural features responsible for increasing biological
activity within the active site and explained the correla-
tion between biological activity and receptor-ligand inter-
actions. These results can offer useful information for the
design of new B-Raf inhibitor.
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